Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Longeveron Inc (LGVN)

Longeveron Inc (LGVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update GlobeNewswire - Tue Nov 12, 3:05PM CST

LGVN : 1.8700 (+1.08%)
LGVNR : 0.0005 (-37.50%)
Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC) GlobeNewswire - Mon Nov 11, 8:05AM CST

LGVN : 1.8700 (+1.08%)
LGVNR : 0.0005 (-37.50%)
Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024 GlobeNewswire - Mon Nov 4, 3:05PM CST

LGVN : 1.8700 (+1.08%)
LGVNR : 0.0005 (-37.50%)
Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) GlobeNewswire - Tue Oct 29, 9:00AM CDT

LGVN : 1.8700 (+1.08%)
LGVNR : 0.0005 (-37.50%)
Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting GlobeNewswire - Sun Oct 27, 2:10PM CDT

LGVN : 1.8700 (+1.08%)
LGVNR : 0.0005 (-37.50%)
Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) GlobeNewswire - Mon Oct 14, 8:05AM CDT

LGVN : 1.8700 (+1.08%)
LGVNR : 0.0005 (-37.50%)
Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting GlobeNewswire - Wed Oct 9, 8:05AM CDT

LGVN : 1.8700 (+1.08%)
LGVNR : 0.0005 (-37.50%)
Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day GlobeNewswire - Mon Oct 7, 8:05AM CDT

LGVN : 1.8700 (+1.08%)
LGVNR : 0.0005 (-37.50%)
Annovis Bio (NYSE: ANVS) Presented Recent Achievements at H.C. Wainwright Conference Investor Brand Network - Thu Sep 26, 9:15AM CDT

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease...

LGVN : 1.8700 (+1.08%)
ANVS : 6.79 (+3.82%)
AVXL : 9.02 (+6.43%)
Wall Street - shutterstock_1321462400
Stocks Set to Open Higher as Investors Await U.S. Jobs Data and Big Tech Earnings, Fed Meeting on Tap Barchart - Mon Jul 29, 4:39AM CDT

September S&P 500 E-Mini futures (ESU24) are up +0.29%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.38% this morning as market participants looked ahead to earnings reports from major tech...

ESU24 : 5,699.99s (-0.31%)
NQU24 : 19,808.01s (-0.21%)
MMM : 127.32 (-0.41%)
CHTR : 383.84 (-1.36%)
DECK : 181.91 (+3.15%)
DXCM : 74.46 (-1.04%)
MSFT : 412.87 (-0.63%)
AMZN : 198.38 (-2.22%)
META : 563.09 (-0.43%)
AAPL : 228.52 (-0.21%)
SBUX : 100.06 (+1.83%)
MCD : 288.47 (-0.84%)

Barchart Exclusives

1 AI Stock to Buy and Hold for Long-Term Growth Barchart - Thu Nov 21, 7:18PM CST
Pure Storage stands out in AI data storage, bolstered by a new partnership with CoreWeave and a solid financial track record, making it an intriguing stock for AI-focused investors Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot